Key references: Diabetes secondary to pancreatic disorders

  • Brunicardi FC, Chaiken RL, Ryan AS, Seymour NE, Hoffmann JA, Lebovitz HE, et al. Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis. J Clin Endocrinol Metab 1996;81(10):3566–72. https://www.ncbi.nlm.nih.gov/pubmed/8855802
  • Cui Y, Andersen DK. Pancreatogenic diabetes: special considerations for management. Pancreatology 2011;11(3):279–94. https://www.ncbi.nlm.nih.gov/pubmed/21757968
  • Diabetes Australia. Position statement. A new language for diabetes. Canberra: Diabetes Australia; 2016. https://www.diabetesaustralia.com.au/position-statements
  • Ewald N, Kaufmann C, Raspe A, Kloer HU, Bretzel RG, Hardt PD. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev 2012;28(4):338–42. https://www.ncbi.nlm.nih.gov/pubmed/22121010
  • Hart PA, Bellin MD, Andersen DK, Bradley D, Cruz-Monserrate Z, Forsmark CE, et al. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol 2016;1(3):226–37. https://www.ncbi.nlm.nih.gov/pubmed/28404095
  • Lohr JM, Dominguez-Munoz E, Rosendahl J, Besselink M, Mayerle J, Lerch MM, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J 2017;5(2):153–99. https://www.ncbi.nlm.nih.gov/pubmed/28344786
  • Petrov MS. Diabetes of the exocrine pancreas: American Diabetes Association-compliant lexicon. Pancreatology 2017;17(4):523–6. https://www.ncbi.nlm.nih.gov/pubmed/28655595
  • Sikkens EC, Cahen DL, Koch AD, Braat H, Poley JW, Kuipers EJ, et al. The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. Pancreatology 2013;13(3):238–42. https://www.ncbi.nlm.nih.gov/pubmed/23719594
  • Woodmansey C, McGovern AP, McCullough KA, Whyte MB, Munro NM, Correa AC, et al. Incidence, demographics, and clinical characteristics of diabetes of the exocrine pancreas (type 3c): a retrospective cohort study. Diabetes Care 2017;40(11):1486–93. https://www.ncbi.nlm.nih.gov/pubmed/28860126
  • Working Party of the Australasian Pancreatic Club, Smith RC, Smith SF, Wilson J, Pearce C, Wray N, et al. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology 2016;16(2):164–80. https://www.ncbi.nlm.nih.gov/pubmed/26775768